RIPE-KG · Version 1.1.0 · Resource
ripekg:work/RIPEW8992528FB0192486
https://w3id.org/ripe/ripe-kg/work/RIPEW8992528FB0192486
| Subject | Predicate | Object |
|---|---|---|
ripekg:work/10.1016%2Fj.lana.2022.100268Hydroxychloroquine for COVID19: The curtains close on a comedy of errors |
http://purl.org/spar/cito/cites |
ripekg:work/RIPEW8992528FB0192486In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
ripekg:work/RIPEW8992528FB0192486In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
dcterms:title |
In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
ripekg:work/RIPEW8992528FB0192486In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
rdf:type |
node1 |
ripekg:work/RIPEW8992528FB0192486In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/RIPEW8992528FB0192486In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
rdf:type |
rdfs:Resource |
ripekg:work/RIPEW8992528FB0192486In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
rdf:type |
owl:Thing |
ripekg:work/RIPEW8992528FB0192486In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
rdf:type |
prov:Entity |
ripekg:work/RIPEW8992528FB0192486In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) |
rdf:type |
ripe:WorkWork |